ONCE - Spark Therapeutics Tue 24'th Jan 2017
Strong Buy Candidate
Stock analysis for Tue 24'th Jan 2017 (Updated daily)
Buy candidate since 2017-01-20
Spark Therapeutics Stock Analysis
Spark Therapeutics gained 1.32% in the last trading day, rising from USD 57.63 to USD 58.39. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a -6.56% loss for the last 2 weeks. Volume also increased in the last day along with the price, which is a positive technical sign, and, in total, 48 448 more shares were traded than the day before. In total, 359 233 shares bought and sold for approximately USD 20.98 million.
Spark Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.9% during the next 3 months and, with 90% probability hold a price between USD 51.45 and USD 75.14 at the end of this period.
Only positive signals in the chart today. Spark Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at USD 56.68 and USD 54.37. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday January 17, 2017, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 59 and the stock is currently not being overbought or oversold
Support & Resistance
Spark Therapeutics finds support from accumulated volume at USD 57.56, USD 50.59, and USD 44.10. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 59.49, USD 62.49 and USD 62.63.
The stock is about to test the resistance from accumulated volume at USD 59.49 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 2.69 between high and low, or 4.80%. For the last week, the stock has had a daily average volatility of 5.04%.
Our recommended stoploss: USD 55.78 (-4.47%) ( criteria: risk and position in trend)
Spark Therapeutics holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at current levels and are expecting further gains during the next 3 months.